Loading...
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh
Kuravi, Sudhakiranmayi
Parrott, Elizabeth
Mudduluru, Giridhar
Cheng, Janice
Ganguly, Siddhartha
Saunthararajah, Yogen
Jensen, Roy A.
Blagg, Brian S.
McGuirk, Joseph P.
Balusu, Ramesh
Citations
Altmetric:
Abstract
Description
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.
Date
2019-01-29
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Research Projects
Organizational Units
Journal Issue
Keywords
T-cell lymphoma, Targeted therapies
Citation
Kuravi, S., Parrott, E., Mudduluru, G. et al. CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas. Blood Cancer Journal 9, 14 (2019). https://doi.org/10.1038/s41408-019-0171-2